How intravenous immunoglobulin is used in clinical practice: Audits of two Sydney teaching hospitals

Internal Medicine Journal

Volumn 37, Issue 5, 2007, Pages 308-314

  Lin, M W ^a,b   Kirkpatrick, P E ^a,c   Riminton, D S ^a,b,c  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c Australasian Society of Clinical Immunology and Allergy (ASCIA)   (Australia)

Author keywords

Audit; Immunodeficiency; Intravenous immunoglobulin; IVIg; Quality

Indexed keywords

IMMUNOGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL PRACTICE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; DERMATOMYOSITIS; DRUG APPROVAL; DRUG COST; DRUG INDICATION; FEMALE; HEMATOLOGY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOGLOBULIN G DEFICIENCY; IMMUNOLOGY; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; MOTOR NEUROPATHY; MULTIPLE MYELOMA; MYASTHENIA GRAVIS; NEUROLOGY; NONHODGKIN LYMPHOMA; PATIENT COMPLIANCE; POLYMYOSITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; TEACHING HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS, TEACHING; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; INFANT, NEWBORN; MALE; MEDICAL AUDIT; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 34248367284     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01336.x     Document Type: Article

References (3)

1. Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981 1: 1228 31.
2. Looney RJ, Huggins J. Use of intravenous immunoglobulin G (IVIG). Best Pract Res Clin Haematol 2006 19: 3 25.
3. Australian Health Ministers' Advisory Council. Review of the use and supply of intravenous immunoglobulins in Australia. A report by the Blood and Blood Products Committee. June 2000. http://www.nba.gov.au/PDF/IVIg.pdf cited June 2000 cited November 2004 N, Konig A, Schroder M, Beranek H, Schoser BGH, Spaeth M et al. Prediction of response to IVIg treatment in patients with lower motor neurone disorders. Eur J Neurol 2006 13: 135 140.